View Mode
Q: 20
Choose 1 option. Cumulus Pharma wants to launch a new product, “Immunexis,” and mandates that field sales reps must capture explicit opt-in consent from Healthcare Providers (HCPs) before sending any digital marketing materials. The following records are already configured in Agentforce Life Sciences: Data Use Purpose record for “Immunexis Marketing” Communication Subscription record named “Immunexis KOL Webinar Series” Engagement Channel Type record for “Email” When reps attempt to capture consent on their iPads, they can see the “Immunexis KOL Webinar Series” subscription, but they cannot select “Email” as a channel to capture the opt-in preference. Which step resolves this issue so the rep can select “Email” for this subscription?
Options
Question 20 of 25

Premium Access Includes

  • Quiz Simulator
  • Exam Mode
  • Progress Tracking
  • Question Saving
  • Flash Cards
  • Drag & Drops
  • 3 Months Access
  • PDF Downloads
Get Premium Access
Scroll to Top

FLASH OFFER

Days
Hours
Minutes
Seconds

avail 10% DISCOUNT on YOUR PURCHASE